ARTELO BIOSCIENCES INC (ARTL) Stock Income Statement
NASDAQ:ARTL - Nasdaq - US04301G5080 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-8-31) | 2020 (2020-8-31) | 2019 (2019-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 9.93M | 10.29M | 7.44M | 4.69M | 3.21M | |||
| Research and Development | 5.70M | 4.32M | 2.84M | 1.92M | 1.09M | |||
| Selling, General, and Administrative Expenses | 4.23M | 5.96M | 4.60M | 2.77M | 2.12M | |||
| Operating Income | -9.93M | -10.29M | -7.44M | -4.69M | -3.21M | |||
| Interest Income/Expense | 641.00K | 200.00K | 0.00 | 30.00K | 1.01M | |||
| Other Income/Expense | N/A | N/A | 0.00 | 0.00 | 30.00K | |||
| Income Before Taxes | -9.29M | -10.08M | -7.44M | -4.65M | -2.17M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -9.29M | -10.08M | -7.44M | -4.65M | -2.17M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.14 | -3.56 | -5.97 | -18.60 | -15.49 | |||
| Non GAAP EPS | -3.19 | -3.65 | -0.29 | -1.01 | N/A | |||
| Statistics | ||||||||
All data in USD